Lisanti Capital Growth’s CryoPort CYRX Stock Holding History

Lisanti Capital Growth’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-51,645	Closed	-$2.27M	–	143
2020 Q4	$2.27M	Buy	+51,645	New	+$2.46M	0.31%	98

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lisanti Capital Growth's CYRX Position: Q1 2021 in Review

Lisanti Capital Growth sold out of CryoPort (CYRX) in Q1 2021, closing a stake of 51,645 shares — an estimated $2.27M sold.

Lisanti Capital Growth first reported a position in CYRX in Q4 2020 and held it in 1 quarter. The position peaked at $2.27M in Q4 2020. 210 funds tracked by Wall St. Rank hold CYRX as of Q1 2021.

Lisanti Capital Growth reported no remaining CryoPort position as of Q1 2021 after selling out during the quarter.
Lisanti Capital Growth sold 51,645 CryoPort shares in Q1 2021, an estimated $2.27M.
Lisanti Capital Growth first reported a position in CryoPort in Q4 2020 and held it in 1 quarter.
Lisanti Capital Growth's CryoPort position peaked at $2.27M in Q4 2020.
210 funds tracked by Wall St. Rank held CryoPort as of Q1 2021.

Based on Lisanti Capital Growth's 13F filing for Q1 2021, filed 12 May 2021.